Targeting the osteosarcoma immune microenvironment for improved immunotherapy and translational applications
Abstract Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. Despite advances in surgery and chemotherapy, outcomes remain poor in metastatic cases, with five-year survival rates below 30%. This stagnation highlights the urgent need for novel therapeutic st...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2025-12-01
|
| Col·lecció: | Discover Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s12672-025-04315-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|